Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$12.15 - $35.28 $1.01 Million - $2.93 Million
-83,103 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $836,462 - $1.33 Million
27,434 Added 49.28%
83,103 $2.84 Million
Q3 2021

Nov 09, 2021

SELL
$41.66 - $52.52 $27,412 - $34,558
-658 Reduced 1.17%
55,669 $2.69 Million
Q2 2021

Jul 29, 2021

SELL
$36.62 - $51.69 $78,366 - $110,616
-2,140 Reduced 3.66%
56,327 $2.54 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $14,587 - $21,017
-351 Reduced 0.6%
58,467 $2.82 Million
Q4 2020

Feb 16, 2021

SELL
$36.08 - $56.47 $85,473 - $133,777
-2,369 Reduced 3.87%
58,818 $3.17 Million
Q3 2020

Nov 16, 2020

BUY
$33.26 - $40.48 $195,801 - $238,305
5,887 Added 10.65%
61,187 $2.26 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $282,838 - $476,410
-13,797 Reduced 19.97%
55,300 $1.53 Million
Q4 2019

Jan 29, 2020

SELL
$18.96 - $29.84 $30,544 - $48,072
-1,611 Reduced 2.28%
69,097 $2.02 Million
Q3 2019

Oct 30, 2019

SELL
$19.12 - $26.24 $1.12 Million - $1.54 Million
-58,792 Reduced 45.4%
70,708 $1.35 Million
Q2 2019

Aug 01, 2019

SELL
$19.57 - $24.1 $188,204 - $231,769
-9,617 Reduced 6.91%
129,500 $2.84 Million
Q1 2019

May 01, 2019

SELL
$12.14 - $20.46 $65,046 - $109,624
-5,358 Reduced 3.71%
139,117 $2.85 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $605,037 - $995,836
-53,829 Reduced 27.14%
144,475 $1.82 Million
Q3 2018

Oct 25, 2018

SELL
$12.5 - $15.38 $568,750 - $699,790
-45,500 Reduced 18.66%
198,304 $3.04 Million
Q2 2018

Aug 02, 2018

SELL
$7.99 - $14.05 $11,186 - $19,670
-1,400 Reduced 0.57%
243,804 $3.2 Million
Q1 2018

Apr 25, 2018

SELL
$7.23 - $8.76 $408,675 - $495,159
-56,525 Reduced 18.73%
245,204 $2 Million
Q4 2017

Jan 23, 2018

SELL
$8.02 - $11.18 $123,098 - $171,601
-15,349 Reduced 4.84%
301,729 $2.67 Million
Q3 2017

Oct 30, 2017

BUY
$9.11 - $11.26 $2.89 Million - $3.57 Million
317,078
317,078 $3.53 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.